RCMI Coordinating Center (RCMI CC) Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Charlton, Clivel
One or more keywords matched the following items that are connected to Charlton, Clivel
Item TypeName
Academic Article S-adenosyl-methionine-induced apoptosis in PC12 cells.
Concept Parkinson Disease
Concept Parkinson Disease, Secondary
Concept Parkinsonian Disorders
Academic Article Excessive S-adenosyl-L-methionine-dependent methylation increases levels of methanol, formaldehyde and formic acid in rat brain striatal homogenates: possible role in S-adenosyl-L-methionine-induced Parkinson's disease-like disorders.
Academic Article L-Dihydroxyphenylalanine modulates the steady-state expression of mouse striatal tyrosine hydroxylase, aromatic L-amino acid decarboxylase, dopamine and its metabolites in an MPTP mouse model of Parkinson's disease.
Academic Article Prenatal exposure to methanol as a dopamine system sensitization model in C57BL/6J mice.
Academic Article Effects of acute and sub-chronic L-dopa therapy on striatal L-dopa methylation and dopamine oxidation in an MPTP mouse model of Parkinsons disease.
Grant PARKINSONISM--A METHYL-DONOR ACTION FOR MPP+
Grant EXCESS METHYLATION &PARKINSONS DISEASE--PROPOSALS
Academic Article Parkinson's disease-like effects of S-adenosyl-L-methionine: effects of L-dopa.
Academic Article Substantia nigra degeneration and tyrosine hydroxylase depletion caused by excess S-adenosylmethionine in the rat brain. Support for an excess methylation hypothesis for parkinsonism.
Academic Article The effects of L-dopa on the activity of methionine adenosyltransferase: relevance to L-dopa therapy and tolerance.
Academic Article S-adenosyl-L-methionine decreases motor activity in the rat: similarity to Parkinson's disease-like symptoms.
Academic Article Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration.
Search Criteria
  • Parkinsonian Disorders
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support